[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 87 Agreed to Senate (ATS)]







110th CONGRESS
  1st Session
S. RES. 87

 Expressing the sense of the Senate that the President should declare 
      lung cancer a public health priority and should implement a 
 comprehensive interagency program to reduce the lung cancer mortality 
                  rate by at least 50 percent by 2015.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                           February 27, 2007

 Mr. Hagel (for himself, Mrs. Clinton, Mr. Brownback, Mrs. Feinstein, 
 and Mr. Brown) submitted the following resolution; which was referred 
       to the Committee on Health, Education, Labor, and Pensions

                             August 2, 2007

             Committee discharged; considered and agreed to

_______________________________________________________________________

                               RESOLUTION


 
 Expressing the sense of the Senate that the President should declare 
      lung cancer a public health priority and should implement a 
 comprehensive interagency program to reduce the lung cancer mortality 
                  rate by at least 50 percent by 2015.

Whereas lung cancer is the leading cause of cancer death for both men and women, 
        accounting for 28 percent of all cancer deaths;
Whereas lung cancer kills more people annually than breast cancer, prostate 
        cancer, colon cancer, liver cancer, melanoma, and kidney cancer 
        combined;
Whereas, since the National Cancer Act of 1971 (Public Law 92-218; 85 Stat. 
        778), coordinated and comprehensive research has raised the 5-year 
        survival rates for breast cancer to 88 percent, for prostate cancer to 
        99 percent, and for colon cancer to 64 percent;
Whereas the 5-year survival rate for lung cancer is still only 15 percent and a 
        similar coordinated and comprehensive research effort is required to 
        achieve increases in lung cancer survivability rates;
Whereas 60 percent of lung cancer cases are now diagnosed in nonsmokers or 
        former smokers;
Whereas \2/3\ of nonsmokers diagnosed with lung cancer are women;
Whereas certain minority populations, such as Black males, have 
        disproportionately high rates of lung cancer incidence and mortality, 
        notwithstanding their lower smoking rate;
Whereas members of the baby boomer generation are entering their sixties, the 
        most common age at which people develop cancer;
Whereas tobacco addiction and exposure to other lung cancer carcinogens such as 
        Agent Orange and other herbicides and battlefield emissions are serious 
        problems among military personnel and war veterans;
Whereas the August 2001 Report of the Lung Cancer Progress Review Group of the 
        National Cancer Institute stated that funding for lung cancer research 
        was ``far below the levels characterized for other common malignancies 
        and far out of proportion to its massive health impact'';
Whereas the Report of the Lung Cancer Progress Review Group identified as its 
        ``highest priority'' the creation of integrated, multidisciplinary, 
        multi-institutional research consortia organized around the problem of 
        lung cancer rather than around specific research disciplines; and
Whereas the United States must enhance its response to the issues raised in the 
        Report of the Lung Cancer Progress Review Group: Now, therefore, be it
    Resolved, That it is the sense of the Senate that the President 
should--
            (1) declare lung cancer a public health priority and 
        immediately lead a coordinated effort to reduce the lung cancer 
        mortality rate by 50 percent by 2015;
            (2) direct the Secretary of Health and Human Services to 
        increase funding for lung cancer research and other lung 
        cancer-related programs as part of a coordinated strategy with 
        defined goals, including--
                    (A) translational research and specialized lung 
                cancer research centers;
                    (B) expansion of existing multi-institutional, 
                population-based screening programs incorporating 
                state-of-the-art image processing, centralized review, 
                clinical management, and tobacco cessation protocols;
                    (C) research on disparities in lung cancer 
                incidence and mortality rates;
                    (D) graduate medical education programs in thoracic 
                medicine and cardiothoracic surgery;
                    (E) new programs within the Food and Drug 
                Administration to expedite the development of 
                chemoprevention and targeted therapies for lung cancer;
                    (F) annual reviews by the Agency for Healthcare 
                Research and Quality of lung cancer screening and 
                treatment protocols;
                    (G) the appointment of a lung cancer director 
                within the Centers for Disease Control and Prevention 
                with authority to improve lung cancer surveillance and 
                screening programs; and
                    (H) lung cancer screening demonstration programs 
                under the direction of the Centers for Medicare and 
                Medicaid Services;
            (3) direct the Secretary of Defense, in conjunction with 
        the Secretary of Veterans Affairs, to develop a broad-based 
        lung cancer screening and disease management program among 
        members of the Armed Forces and veterans, and to develop 
        technologically advanced diagnostic programs for the early 
        detection of lung cancer;
            (4) appoint a Lung Cancer Scientific and Medical Advisory 
        Committee, comprised of medical, scientific, pharmaceutical, 
        and patient advocacy representatives, to--
                    (A) work with the National Lung Cancer Public 
                Health Policy Board described in paragraph (5); and
                    (B) report to the President and Congress on the 
                progress toward and the obstacles to achieving the goal 
                described in paragraph (1) of reducing the lung cancer 
                mortality rate by 50 percent by 2015; and
            (5) convene a National Lung Cancer Public Health Policy 
        Board, comprised of multiagency and multidepartment 
        representatives and at least 3 members of the Lung Cancer 
        Scientific and Medical Advisory Committee, to oversee and 
        coordinate all efforts to accomplish the goal described in 
        paragraph (1) of reducing the lung cancer mortality rate by 50 
        percent by 2015.
                                 <all>